ReP USP - Resultado da busca

Artigo de periodico
Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole (2008)
Almeida, Madson Queiroz; Brito, Vinicius Nahime; Lins, Thereza Selma S.; Guerra-Júnior, Gil; Castro, Margaret de; Antonini, Sonir Roberto; Arnhold, Ivo Jorge Prado; Mendonça, Berenice Bilharinho; Latronico, Ana Claudia
Fonte: Clinical Endocrinology. Unidades: FM, FMRP
Assuntos: ENDOCRINOLOGIA, PUBERDADE PRECOCE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Madson Queiroz et al. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole. Clinical Endocrinology, v. 69, n. 1, p. 93-98, 2008Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2007.03160.x. Acesso em: 31 out. 2024.
APA
Almeida, M. Q., Brito, V. N., Lins, T. S. S., Guerra-Júnior, G., Castro, M. de, Antonini, S. R., et al. (2008). Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole. Clinical Endocrinology, 69( 1), 93-98. doi:10.1111/j.1365-2265.2007.03160.x
NLM
Almeida MQ, Brito VN, Lins TSS, Guerra-Júnior G, Castro M de, Antonini SR, Arnhold IJP, Mendonça BB, Latronico AC. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole [Internet]. Clinical Endocrinology. 2008 ; 69( 1): 93-98.[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/j.1365-2265.2007.03160.x
Vancouver
Almeida MQ, Brito VN, Lins TSS, Guerra-Júnior G, Castro M de, Antonini SR, Arnhold IJP, Mendonça BB, Latronico AC. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole [Internet]. Clinical Endocrinology. 2008 ; 69( 1): 93-98.[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/j.1365-2265.2007.03160.x
Artigo de periodico
Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion (2006)
Abrão, Milena Garcia; Leitet, M. V.; Carvalho, L. R.; Billerbeck, A. E. C.; Nishi, M. Y.; Barbosa, A. S.; Martin, R. M.; Arnhold, I. J. P.; Mendonça, Berenice Bilharinho
Fonte: Clinical Endocrinology. Unidade: FM
Assuntos: ENDOCRINOLOGIA, HORMÔNIOS HIPOFISÁRIOS (DEFICIÊNCIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABRÃO, Milena Garcia et al. Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion. Clinical Endocrinology, v. 65, n. 3, p. 294-300, 2006Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2006.02592.x. Acesso em: 31 out. 2024.
APA
Abrão, M. G., Leitet, M. V., Carvalho, L. R., Billerbeck, A. E. C., Nishi, M. Y., Barbosa, A. S., et al. (2006). Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion. Clinical Endocrinology, 65( 3), 294-300. doi:10.1111/j.1365-2265.2006.02592.x
NLM
Abrão MG, Leitet MV, Carvalho LR, Billerbeck AEC, Nishi MY, Barbosa AS, Martin RM, Arnhold IJP, Mendonça BB. Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion [Internet]. Clinical Endocrinology. 2006 ; 65( 3): 294-300.[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/j.1365-2265.2006.02592.x
Vancouver
Abrão MG, Leitet MV, Carvalho LR, Billerbeck AEC, Nishi MY, Barbosa AS, Martin RM, Arnhold IJP, Mendonça BB. Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion [Internet]. Clinical Endocrinology. 2006 ; 65( 3): 294-300.[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/j.1365-2265.2006.02592.x
Artigo de periodico
The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH anlogue therapy not restored by dihydrotestosterone administration (2004)
Jorge, Alexander A. L.; Souza, Silvia C. A. L.; Arnhold, Ivo J. P.; Mendonça, Berenice B.
Fonte: Clinical Endocrinology. Unidade: FM
Assunto: ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JORGE, Alexander A. L. et al. The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH anlogue therapy not restored by dihydrotestosterone administration. Clinical Endocrinology, v. 60, p. 36-40, 2004Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2004.01930.x. Acesso em: 31 out. 2024.
APA
Jorge, A. A. L., Souza, S. C. A. L., Arnhold, I. J. P., & Mendonça, B. B. (2004). The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH anlogue therapy not restored by dihydrotestosterone administration. Clinical Endocrinology, 60, 36-40. doi:10.1111/j.1365-2265.2004.01930.x
NLM
Jorge AAL, Souza SCAL, Arnhold IJP, Mendonça BB. The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH anlogue therapy not restored by dihydrotestosterone administration [Internet]. Clinical Endocrinology. 2004 ; 60 36-40.[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/j.1365-2265.2004.01930.x
Vancouver
Jorge AAL, Souza SCAL, Arnhold IJP, Mendonça BB. The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH anlogue therapy not restored by dihydrotestosterone administration [Internet]. Clinical Endocrinology. 2004 ; 60 36-40.[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/j.1365-2265.2004.01930.x
Artigo de periodico
Acromegalic features in growth hormore (GH)-deficient patients after long-term GH therapy (2003)
Carvalho, Luciani R.; Faria, Maria Estela Justamante de; Osorio, Maria Geralda Farah; Estefan, Vivian; Jorge, Alexander Augusto Lima; Arnhold, Ivo Jorge P.; Mendonça, Berenice B.
Fonte: Clinical Endocrinology. Unidade: FM
Assunto: ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Luciani R. et al. Acromegalic features in growth hormore (GH)-deficient patients after long-term GH therapy. Clinical Endocrinology, v. 59, p. 788-792, 2003Tradução . . Disponível em: https://doi.org/10.1046/j.1365-2265.2003.01899.x. Acesso em: 31 out. 2024.
APA
Carvalho, L. R., Faria, M. E. J. de, Osorio, M. G. F., Estefan, V., Jorge, A. A. L., Arnhold, I. J. P., & Mendonça, B. B. (2003). Acromegalic features in growth hormore (GH)-deficient patients after long-term GH therapy. Clinical Endocrinology, 59, 788-792. doi:10.1046/j.1365-2265.2003.01899.x
NLM
Carvalho LR, Faria MEJ de, Osorio MGF, Estefan V, Jorge AAL, Arnhold IJP, Mendonça BB. Acromegalic features in growth hormore (GH)-deficient patients after long-term GH therapy [Internet]. Clinical Endocrinology. 2003 ; 59 788-792.[citado 2024 out. 31 ] Available from: https://doi.org/10.1046/j.1365-2265.2003.01899.x
Vancouver
Carvalho LR, Faria MEJ de, Osorio MGF, Estefan V, Jorge AAL, Arnhold IJP, Mendonça BB. Acromegalic features in growth hormore (GH)-deficient patients after long-term GH therapy [Internet]. Clinical Endocrinology. 2003 ; 59 788-792.[citado 2024 out. 31 ] Available from: https://doi.org/10.1046/j.1365-2265.2003.01899.x
Artigo de periodico
Glucocorticoid receptor gene polymorphism in ACTH-secreting pituitary tumours (2002)
Antonini, S. R. R.; Latronico, Ana Claudia; Elias, L. L. K.; Cukier, A.; Machado, H. R.; Liberman, Bernardo; Mendonça, Berenice B.; Moreira, Ayrton Custódio; Castro, M.
Fonte: Clinical Endocrinology. Unidade: FM
Assunto: ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTONINI, S. R. R. et al. Glucocorticoid receptor gene polymorphism in ACTH-secreting pituitary tumours. Clinical Endocrinology, v. 57, n. 05, p. 657-662, 2002Tradução . . Disponível em: https://doi.org/10.1046/j.1365-2265.2002.01639.x. Acesso em: 31 out. 2024.
APA
Antonini, S. R. R., Latronico, A. C., Elias, L. L. K., Cukier, A., Machado, H. R., Liberman, B., et al. (2002). Glucocorticoid receptor gene polymorphism in ACTH-secreting pituitary tumours. Clinical Endocrinology, 57( 05), 657-662. doi:10.1046/j.1365-2265.2002.01639.x
NLM
Antonini SRR, Latronico AC, Elias LLK, Cukier A, Machado HR, Liberman B, Mendonça BB, Moreira AC, Castro M. Glucocorticoid receptor gene polymorphism in ACTH-secreting pituitary tumours [Internet]. Clinical Endocrinology. 2002 ; 57( 05): 657-662.[citado 2024 out. 31 ] Available from: https://doi.org/10.1046/j.1365-2265.2002.01639.x
Vancouver
Antonini SRR, Latronico AC, Elias LLK, Cukier A, Machado HR, Liberman B, Mendonça BB, Moreira AC, Castro M. Glucocorticoid receptor gene polymorphism in ACTH-secreting pituitary tumours [Internet]. Clinical Endocrinology. 2002 ; 57( 05): 657-662.[citado 2024 out. 31 ] Available from: https://doi.org/10.1046/j.1365-2265.2002.01639.x
Artigo de periodico
Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations (2002)
Pasoto, Sandra Gofinet; Mendonça, Berenice Bilharinho de; Bonfá, Eloísa Silva Dutra de Oliveira
Fonte: Lupus. Unidades: HU, FM
Assuntos: AMENORREIA, ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASOTO, Sandra Gofinet e MENDONÇA, Berenice Bilharinho de e BONFÁ, Eloísa Silva Dutra de Oliveira. Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations. Lupus, v. 11, p. 175-180, 2002Tradução . . Acesso em: 31 out. 2024.
APA
Pasoto, S. G., Mendonça, B. B. de, & Bonfá, E. S. D. de O. (2002). Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations. Lupus, 11, 175-180.
NLM
Pasoto SG, Mendonça BB de, Bonfá ESD de O. Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations. Lupus. 2002 ; 11 175-180.[citado 2024 out. 31 ]
Vancouver
Pasoto SG, Mendonça BB de, Bonfá ESD de O. Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations. Lupus. 2002 ; 11 175-180.[citado 2024 out. 31 ]
Artigo de periodico
Interferon-alpha therapy increases type I insulin-like growth factor receptors expression on lymphoid cells from patients with chronic myelogenous leukemia (2001)
Oliveira, Maria Regina; Ohnuma, Lucia; Bendit, Israel; Dorlhiac-Lacer, Pedro; Gianella-Neto, Daniel
Fonte: Leukemia Research. Unidade: FM
Assuntos: INTERFERONS, ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Maria Regina et al. Interferon-alpha therapy increases type I insulin-like growth factor receptors expression on lymphoid cells from patients with chronic myelogenous leukemia. Leukemia Research, n. 25, p. 711-717, 2001Tradução . . Disponível em: https://doi.org/10.1016/s0145-2126(01)00011-x. Acesso em: 31 out. 2024.
APA
Oliveira, M. R., Ohnuma, L., Bendit, I., Dorlhiac-Lacer, P., & Gianella-Neto, D. (2001). Interferon-alpha therapy increases type I insulin-like growth factor receptors expression on lymphoid cells from patients with chronic myelogenous leukemia. Leukemia Research, ( 25), 711-717. doi:10.1016/s0145-2126(01)00011-x
NLM
Oliveira MR, Ohnuma L, Bendit I, Dorlhiac-Lacer P, Gianella-Neto D. Interferon-alpha therapy increases type I insulin-like growth factor receptors expression on lymphoid cells from patients with chronic myelogenous leukemia [Internet]. Leukemia Research. 2001 ;( 25): 711-717.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/s0145-2126(01)00011-x
Vancouver
Oliveira MR, Ohnuma L, Bendit I, Dorlhiac-Lacer P, Gianella-Neto D. Interferon-alpha therapy increases type I insulin-like growth factor receptors expression on lymphoid cells from patients with chronic myelogenous leukemia [Internet]. Leukemia Research. 2001 ;( 25): 711-717.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/s0145-2126(01)00011-x
Trabalho de evento-anais periodico
Clinical and molecular analysis of three Mexican families with Pendred's syndrome (2001)
Trevino, O. Gonzalez; Arseven Karamanoglu, O.; Ceballos, C. J.; Vives, V. I.; Ramirez, R. C.; Gomez, V. V.; Medeiros-Neto, G.; Kopp, P.
Fonte: European Journal of Endocrinology. Unidade: FM
Assuntos: CLÍNICA GERAL, ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TREVINO, O. Gonzalez et al. Clinical and molecular analysis of three Mexican families with Pendred's syndrome. European Journal of Endocrinology. Reino Unido: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2001
APA
Trevino, O. G., Arseven Karamanoglu, O., Ceballos, C. J., Vives, V. I., Ramirez, R. C., Gomez, V. V., et al. (2001). Clinical and molecular analysis of three Mexican families with Pendred's syndrome. European Journal of Endocrinology. Reino Unido: Faculdade de Medicina, Universidade de São Paulo.
NLM
Trevino OG, Arseven Karamanoglu O, Ceballos CJ, Vives VI, Ramirez RC, Gomez VV, Medeiros-Neto G, Kopp P. Clinical and molecular analysis of three Mexican families with Pendred's syndrome. European Journal of Endocrinology. 2001 ; 144( 6): 585-593.[citado 2024 out. 31 ]
Vancouver
Trevino OG, Arseven Karamanoglu O, Ceballos CJ, Vives VI, Ramirez RC, Gomez VV, Medeiros-Neto G, Kopp P. Clinical and molecular analysis of three Mexican families with Pendred's syndrome. European Journal of Endocrinology. 2001 ; 144( 6): 585-593.[citado 2024 out. 31 ]
Artigo de periodico
Prevalence and characteristics of postpartum thyroid dysfunction in São Paulo, Brazil (2000)
Barca, Maria Fernanda; Knobel, Meyer; Tomimori, Eduardo; Cardia, Maria Silvia; Medeiros Neto, Geraldo Antônio
Fonte: Clinical Endocrinology. Unidade: FM
Assunto: ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARCA, Maria Fernanda et al. Prevalence and characteristics of postpartum thyroid dysfunction in São Paulo, Brazil. Clinical Endocrinology, v. 53, p. 21-31, 2000Tradução . . Disponível em: https://doi.org/10.1046/j.1365-2265.2000.01034.x. Acesso em: 31 out. 2024.
APA
Barca, M. F., Knobel, M., Tomimori, E., Cardia, M. S., & Medeiros Neto, G. A. (2000). Prevalence and characteristics of postpartum thyroid dysfunction in São Paulo, Brazil. Clinical Endocrinology, 53, 21-31. doi:10.1046/j.1365-2265.2000.01034.x
NLM
Barca MF, Knobel M, Tomimori E, Cardia MS, Medeiros Neto GA. Prevalence and characteristics of postpartum thyroid dysfunction in São Paulo, Brazil [Internet]. Clinical Endocrinology. 2000 ; 53 21-31.[citado 2024 out. 31 ] Available from: https://doi.org/10.1046/j.1365-2265.2000.01034.x
Vancouver
Barca MF, Knobel M, Tomimori E, Cardia MS, Medeiros Neto GA. Prevalence and characteristics of postpartum thyroid dysfunction in São Paulo, Brazil [Internet]. Clinical Endocrinology. 2000 ; 53 21-31.[citado 2024 out. 31 ] Available from: https://doi.org/10.1046/j.1365-2265.2000.01034.x
Artigo de periodico
A novel mutation in the TPO gene in goitrous hypothyroid patients with iodide organification defect (1999)
Santos, Cecilia L. S.; Bikker, Hennie; Rego, Katia G. M.; Nascimento, Antonio C.; Tambascia, Marcos; Vijlder, Jan J. M. de; Medeiros Neto, Geraldo Antônio
Fonte: Clinical Endocrinology. Unidade: FM
Assuntos: ENDOCRINOLOGIA, HORMÔNIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Cecilia L. S. et al. A novel mutation in the TPO gene in goitrous hypothyroid patients with iodide organification defect. Clinical Endocrinology, v. 51, n. 2, p. 165-172, 1999Tradução . . Disponível em: https://doi.org/10.1046/j.1365-2265.1999.00746.x. Acesso em: 31 out. 2024.
APA
Santos, C. L. S., Bikker, H., Rego, K. G. M., Nascimento, A. C., Tambascia, M., Vijlder, J. J. M. de, & Medeiros Neto, G. A. (1999). A novel mutation in the TPO gene in goitrous hypothyroid patients with iodide organification defect. Clinical Endocrinology, 51( 2), 165-172. doi:10.1046/j.1365-2265.1999.00746.x
NLM
Santos CLS, Bikker H, Rego KGM, Nascimento AC, Tambascia M, Vijlder JJM de, Medeiros Neto GA. A novel mutation in the TPO gene in goitrous hypothyroid patients with iodide organification defect [Internet]. Clinical Endocrinology. 1999 ; 51( 2): 165-172.[citado 2024 out. 31 ] Available from: https://doi.org/10.1046/j.1365-2265.1999.00746.x
Vancouver
Santos CLS, Bikker H, Rego KGM, Nascimento AC, Tambascia M, Vijlder JJM de, Medeiros Neto GA. A novel mutation in the TPO gene in goitrous hypothyroid patients with iodide organification defect [Internet]. Clinical Endocrinology. 1999 ; 51( 2): 165-172.[citado 2024 out. 31 ] Available from: https://doi.org/10.1046/j.1365-2265.1999.00746.x
Artigo de periodico
Mutations in the ret proto-oncogene and the von hippel-lindau disease tumour supressor gene in sporadic and syndromic phaeochromocytomas (1995)
Eng, C; Crossey, P A; Mulligan, L M; Healey, C S; Houghton, C; Prowse, A; Chew, S L; Dahia, P L M; Oriordan, J L H; Toledo, S. P. A.; Smith, D P; Maher, E R
Fonte: Journal of Medical Genetics. Unidade: FM
Assunto: ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ENG, C et al. Mutations in the ret proto-oncogene and the von hippel-lindau disease tumour supressor gene in sporadic and syndromic phaeochromocytomas. Journal of Medical Genetics, v. 32, n. 12, p. 934-7, 1995Tradução . . Disponível em: https://doi.org/10.1136/jmg.32.12.934. Acesso em: 31 out. 2024.
APA
Eng, C., Crossey, P. A., Mulligan, L. M., Healey, C. S., Houghton, C., Prowse, A., et al. (1995). Mutations in the ret proto-oncogene and the von hippel-lindau disease tumour supressor gene in sporadic and syndromic phaeochromocytomas. Journal of Medical Genetics, 32( 12), 934-7. doi:10.1136/jmg.32.12.934
NLM
Eng C, Crossey PA, Mulligan LM, Healey CS, Houghton C, Prowse A, Chew SL, Dahia PLM, Oriordan JLH, Toledo SPA, Smith DP, Maher ER. Mutations in the ret proto-oncogene and the von hippel-lindau disease tumour supressor gene in sporadic and syndromic phaeochromocytomas [Internet]. Journal of Medical Genetics. 1995 ;32( 12): 934-7.[citado 2024 out. 31 ] Available from: https://doi.org/10.1136/jmg.32.12.934
Vancouver
Eng C, Crossey PA, Mulligan LM, Healey CS, Houghton C, Prowse A, Chew SL, Dahia PLM, Oriordan JLH, Toledo SPA, Smith DP, Maher ER. Mutations in the ret proto-oncogene and the von hippel-lindau disease tumour supressor gene in sporadic and syndromic phaeochromocytomas [Internet]. Journal of Medical Genetics. 1995 ;32( 12): 934-7.[citado 2024 out. 31 ] Available from: https://doi.org/10.1136/jmg.32.12.934
Trabalho de evento-resumo periodico
Lack of evidence of p53 involvement in phaeochromocytoma oncogenesis (1995)
Dahia, P L M; Tsanaclis, Ana Maria Crous; Ezabella, M C L; Hayashida, C Y; Abelin, N M A; Toledo, S. P. A.
Fonte: Journal of Endocrinology. Nome do evento: Joint Meeting of the British Endocrine Societies and European Federation of Endocrine Societies. Unidade: FM
Assunto: ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAHIA, P L M et al. Lack of evidence of p53 involvement in phaeochromocytoma oncogenesis. Journal of Endocrinology. London: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 1995
APA
Dahia, P. L. M., Tsanaclis, A. M. C., Ezabella, M. C. L., Hayashida, C. Y., Abelin, N. M. A., & Toledo, S. P. A. (1995). Lack of evidence of p53 involvement in phaeochromocytoma oncogenesis. Journal of Endocrinology. London: Faculdade de Medicina, Universidade de São Paulo.
NLM
Dahia PLM, Tsanaclis AMC, Ezabella MCL, Hayashida CY, Abelin NMA, Toledo SPA. Lack of evidence of p53 involvement in phaeochromocytoma oncogenesis. Journal of Endocrinology. 1995 ;144( suppl.):[citado 2024 out. 31 ]
Vancouver
Dahia PLM, Tsanaclis AMC, Ezabella MCL, Hayashida CY, Abelin NMA, Toledo SPA. Lack of evidence of p53 involvement in phaeochromocytoma oncogenesis. Journal of Endocrinology. 1995 ;144( suppl.):[citado 2024 out. 31 ]
Trabalho de evento-resumo periodico
Calcitonin (ct) deficiency in chronic hashimoto's thyroiditis (1994)
Borges, M F; Toledo, S. P. A.; Abelin, N M A; Cunha, D F; Barros, M A E
Fonte: European Journal of Endocrinology. Nome do evento: European Congress of Endocrinology. Unidade: FM
Assunto: ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, M F et al. Calcitonin (ct) deficiency in chronic hashimoto's thyroiditis. European Journal of Endocrinology. Oxford: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 1994
APA
Borges, M. F., Toledo, S. P. A., Abelin, N. M. A., Cunha, D. F., & Barros, M. A. E. (1994). Calcitonin (ct) deficiency in chronic hashimoto's thyroiditis. European Journal of Endocrinology. Oxford: Faculdade de Medicina, Universidade de São Paulo.
NLM
Borges MF, Toledo SPA, Abelin NMA, Cunha DF, Barros MAE. Calcitonin (ct) deficiency in chronic hashimoto's thyroiditis. European Journal of Endocrinology. 1994 ;130( ju 1994): 140.[citado 2024 out. 31 ]
Vancouver
Borges MF, Toledo SPA, Abelin NMA, Cunha DF, Barros MAE. Calcitonin (ct) deficiency in chronic hashimoto's thyroiditis. European Journal of Endocrinology. 1994 ;130( ju 1994): 140.[citado 2024 out. 31 ]
Artigo de periodico
Dyshormonogenetic goiter: a morphological and immunohistochemical study (1994)
Matos, P. S.; Bisi, Hélio; Medeiros Neto, Geraldo Antônio
Fonte: Endocrine Pathology. Unidade: FM
Assunto: ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATOS, P. S. e BISI, Hélio e MEDEIROS NETO, Geraldo Antônio. Dyshormonogenetic goiter: a morphological and immunohistochemical study. Endocrine Pathology, v. 5, n. 1, p. 49-58, 1994Tradução . . Disponível em: https://doi.org/10.1007/bf02921370. Acesso em: 31 out. 2024.
APA
Matos, P. S., Bisi, H., & Medeiros Neto, G. A. (1994). Dyshormonogenetic goiter: a morphological and immunohistochemical study. Endocrine Pathology, 5( 1), 49-58. doi:10.1007/bf02921370
NLM
Matos PS, Bisi H, Medeiros Neto GA. Dyshormonogenetic goiter: a morphological and immunohistochemical study [Internet]. Endocrine Pathology. 1994 ; 5( 1): 49-58.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/bf02921370
Vancouver
Matos PS, Bisi H, Medeiros Neto GA. Dyshormonogenetic goiter: a morphological and immunohistochemical study [Internet]. Endocrine Pathology. 1994 ; 5( 1): 49-58.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/bf02921370
Artigo de periodico
Low cor blood levels of catecholamine from a newborn of a pheochromocytoma patient (1994)
Dahia, P L M; Hayashida, C Y; Strunz, C M C; Abelin, N M A; Toledo, S. P. A.
Fonte: European Journal of Endocrinology. Unidade: FM
Assunto: ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DAHIA, P L M et al. Low cor blood levels of catecholamine from a newborn of a pheochromocytoma patient. European Journal of Endocrinology, v. 130, n. 3 , p. 217-9, 1994Tradução . . Disponível em: https://doi.org/10.1530/eje.0.1300217. Acesso em: 31 out. 2024.
APA
Dahia, P. L. M., Hayashida, C. Y., Strunz, C. M. C., Abelin, N. M. A., & Toledo, S. P. A. (1994). Low cor blood levels of catecholamine from a newborn of a pheochromocytoma patient. European Journal of Endocrinology, 130( 3 ), 217-9. doi:10.1530/eje.0.1300217
NLM
Dahia PLM, Hayashida CY, Strunz CMC, Abelin NMA, Toledo SPA. Low cor blood levels of catecholamine from a newborn of a pheochromocytoma patient [Internet]. European Journal of Endocrinology. 1994 ;130( 3 ): 217-9.[citado 2024 out. 31 ] Available from: https://doi.org/10.1530/eje.0.1300217
Vancouver
Dahia PLM, Hayashida CY, Strunz CMC, Abelin NMA, Toledo SPA. Low cor blood levels of catecholamine from a newborn of a pheochromocytoma patient [Internet]. European Journal of Endocrinology. 1994 ;130( 3 ): 217-9.[citado 2024 out. 31 ] Available from: https://doi.org/10.1530/eje.0.1300217
Artigo de periodico
Letters to the editors (1994)
Medeiros Neto, Geraldo Antônio
Fonte: Clinical Endocrinology. Unidade: FM
Assunto: ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDEIROS NETO, Geraldo Antônio. Letters to the editors. Clinical Endocrinology, v. 40, n. 3 , p. 435, 1994Tradução . . Acesso em: 31 out. 2024.
APA
Medeiros Neto, G. A. (1994). Letters to the editors. Clinical Endocrinology, 40( 3 ), 435.
NLM
Medeiros Neto GA. Letters to the editors. Clinical Endocrinology. 1994 ;40( 3 ): 435.[citado 2024 out. 31 ]
Vancouver
Medeiros Neto GA. Letters to the editors. Clinical Endocrinology. 1994 ;40( 3 ): 435.[citado 2024 out. 31 ]
Artigo de periodico
Nonsense mutation causes human hereditary congenital goiter with preferential production of a 171 nucleotide-deleted thyroglobulin ribunocleic acid messenger (1993)
Targovnik, H M; Medeiros Neto, Geraldo Antônio; Varela, V; Cochaux, P; Wajchenberg, B L; Vassart, G
Fonte: Journal of Clinical Endocrinology and Metabolism. Unidade: FM
Assunto: ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TARGOVNIK, H M et al. Nonsense mutation causes human hereditary congenital goiter with preferential production of a 171 nucleotide-deleted thyroglobulin ribunocleic acid messenger. Journal of Clinical Endocrinology and Metabolism, v. 77, n. 1 , p. 210-5, 1993Tradução . . Disponível em: https://doi.org/10.1210/jcem.77.1.8325944. Acesso em: 31 out. 2024.
APA
Targovnik, H. M., Medeiros Neto, G. A., Varela, V., Cochaux, P., Wajchenberg, B. L., & Vassart, G. (1993). Nonsense mutation causes human hereditary congenital goiter with preferential production of a 171 nucleotide-deleted thyroglobulin ribunocleic acid messenger. Journal of Clinical Endocrinology and Metabolism, 77( 1 ), 210-5. doi:10.1210/jcem.77.1.8325944
NLM
Targovnik HM, Medeiros Neto GA, Varela V, Cochaux P, Wajchenberg BL, Vassart G. Nonsense mutation causes human hereditary congenital goiter with preferential production of a 171 nucleotide-deleted thyroglobulin ribunocleic acid messenger [Internet]. Journal of Clinical Endocrinology and Metabolism. 1993 ;77( 1 ): 210-5.[citado 2024 out. 31 ] Available from: https://doi.org/10.1210/jcem.77.1.8325944
Vancouver
Targovnik HM, Medeiros Neto GA, Varela V, Cochaux P, Wajchenberg BL, Vassart G. Nonsense mutation causes human hereditary congenital goiter with preferential production of a 171 nucleotide-deleted thyroglobulin ribunocleic acid messenger [Internet]. Journal of Clinical Endocrinology and Metabolism. 1993 ;77( 1 ): 210-5.[citado 2024 out. 31 ] Available from: https://doi.org/10.1210/jcem.77.1.8325944
Artigo de periodico
Clearence from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man (1993)
Redgrave, T; Ly, H L; Quintão, Eder Carlos da Rocha; Ramberg, C F; Boston, R C
Fonte: Biochemical Journal. Unidade: FM
Assunto: ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REDGRAVE, T et al. Clearence from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man. Biochemical Journal, v. 290, p. 843-7, 1993Tradução . . Disponível em: https://doi.org/10.1042/bj2900843. Acesso em: 31 out. 2024.
APA
Redgrave, T., Ly, H. L., Quintão, E. C. da R., Ramberg, C. F., & Boston, R. C. (1993). Clearence from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man. Biochemical Journal, 290, 843-7. doi:10.1042/bj2900843
NLM
Redgrave T, Ly HL, Quintão EC da R, Ramberg CF, Boston RC. Clearence from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man [Internet]. Biochemical Journal. 1993 ;290 843-7.[citado 2024 out. 31 ] Available from: https://doi.org/10.1042/bj2900843
Vancouver
Redgrave T, Ly HL, Quintão EC da R, Ramberg CF, Boston RC. Clearence from plasma of triacylglycerol and cholesteryl ester after intravenous injection of chylomicron-like lipid emulsions in rats and man [Internet]. Biochemical Journal. 1993 ;290 843-7.[citado 2024 out. 31 ] Available from: https://doi.org/10.1042/bj2900843
Artigo de periodico
Desmopressin stimulation test in the differential diagnosis of cushing's syndrome (1993)
Malerbi, D A; Mendonça, B. B.; Liberman, Bernardo; Toledo, S. P. A.; Corradini, M C M; Cunha Neto, M B C; Fragoso, M C B V; Wajchenberg, B L
Fonte: Clinical Endocrinology. Unidade: FM
Assunto: ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALERBI, D A et al. Desmopressin stimulation test in the differential diagnosis of cushing's syndrome. Clinical Endocrinology, v. 38, n. 5 , p. 463-72, 1993Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.1993.tb00341.x. Acesso em: 31 out. 2024.
APA
Malerbi, D. A., Mendonça, B. B., Liberman, B., Toledo, S. P. A., Corradini, M. C. M., Cunha Neto, M. B. C., et al. (1993). Desmopressin stimulation test in the differential diagnosis of cushing's syndrome. Clinical Endocrinology, 38( 5 ), 463-72. doi:10.1111/j.1365-2265.1993.tb00341.x
NLM
Malerbi DA, Mendonça BB, Liberman B, Toledo SPA, Corradini MCM, Cunha Neto MBC, Fragoso MCBV, Wajchenberg BL. Desmopressin stimulation test in the differential diagnosis of cushing's syndrome [Internet]. Clinical Endocrinology. 1993 ;38( 5 ): 463-72.[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/j.1365-2265.1993.tb00341.x
Vancouver
Malerbi DA, Mendonça BB, Liberman B, Toledo SPA, Corradini MCM, Cunha Neto MBC, Fragoso MCBV, Wajchenberg BL. Desmopressin stimulation test in the differential diagnosis of cushing's syndrome [Internet]. Clinical Endocrinology. 1993 ;38( 5 ): 463-72.[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/j.1365-2265.1993.tb00341.x
Trabalho de evento
Genetic and molecular biological studies in defective iodide organification causing hereditary goiter and hypothyroidism (1993)
Medeiros Neto, Geraldo Antônio; Billerbeck, A E C; Wajchenberg, B L
Fonte: Progress in Endocrinology. Nome do evento: International Congress of the Endocrinology. Unidade: FM
Assunto: ENDOCRINOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDEIROS NETO, Geraldo Antônio e BILLERBECK, A E C e WAJCHENBERG, B L. Genetic and molecular biological studies in defective iodide organification causing hereditary goiter and hypothyroidism. 1993, Anais.. Carnforth: Parthenon, 1993. . Acesso em: 31 out. 2024.
APA
Medeiros Neto, G. A., Billerbeck, A. E. C., & Wajchenberg, B. L. (1993). Genetic and molecular biological studies in defective iodide organification causing hereditary goiter and hypothyroidism. In Progress in Endocrinology. Carnforth: Parthenon.
NLM
Medeiros Neto GA, Billerbeck AEC, Wajchenberg BL. Genetic and molecular biological studies in defective iodide organification causing hereditary goiter and hypothyroidism. Progress in Endocrinology. 1993 ;[citado 2024 out. 31 ]
Vancouver
Medeiros Neto GA, Billerbeck AEC, Wajchenberg BL. Genetic and molecular biological studies in defective iodide organification causing hereditary goiter and hypothyroidism. Progress in Endocrinology. 1993 ;[citado 2024 out. 31 ]

Unidades USP

ReP

Filtros

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Indexado em

Afiliação dos autores externos não normalizada